CytoLynx Therapeutics is a R&D and commercial platform leveraging Cytovia’s unique technologies and product pipeline.
CytoLynx Therapeutics is a R&D and commercial platform leveraging Cytovia’s unique technologies and product pipeline.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Sep 13, 2021 | Funding Round | $45M | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Ruihua Venture Capital | — | Funding Round |